Last Friday, US stocks closed lower across the board, with the S&P 500 Index recording a 'three-day losing streak.' The precious metals market experienced significant volatility, with gold and silver posting their largest single-day drop since 1980. On the news front, Trump's nomination of the hawkish Kevin Warsh as Federal Reserve chairman triggered market concerns over tighter monetary policy.
Currently, market capital is fiercely competing amidst the interplay of Fed policy direction, inflation trajectory, and risk-aversion sentiment, with panic selling becoming increasingly evident. Against this backdrop, ARK remains committed to its investment creed of 'disruptive innovation,' continuing to deepen its presence in the three major tracks of genomics, crypto-assets, and artificial intelligence.

Direction of increased positions: Fully betting on crypto concepts, increasing Amazon holdings
In this round of position increases, genomic companies $GeneDx Holdings (WGS.US)$ ranked first, significantly adding 91,800 shares. Following closely are active players in the digital asset and trading space:
Digital finance remains heated:Cathie Wood continues to be bullish on the crypto ecosystem, increasing her positions in $Bullish (BLSH.US)$ 64,200 shares, $Circle (CRCL.US)$ 23,400 shares, $Robinhood (HOOD.US)$ 19,400 shares, $Coinbase (COIN.US)$ 7,565 shares, and also swept up crypto ETFs with $ARK 21Shares Bitcoin ETF (ARKB.US)$ over 30,000 shares.
Return to traditional giants: Notably, ARK continues to accumulate $Amazon (AMZN.US)$ , purchasing 8,088 shares this round. This shows that in the era of AI large models, Cathie Wood believes e-commerce giants with strong cloud infrastructure and data closed loops still have the potential for a 'second breakout'.It's worth noting that the timing of Cathie Wood’s trades coincides with Amazon's earnings release前夕, the company will announce its latest earnings after market close on February 5.
Hardcore technology:In the autonomous trucking sector, $Kodiak AI (KDK.US)$ also saw a 37,500-share increase in holdings.
Direction of reduction: Continue reducing VCYT & ILMN, sell ROKU
On the selling side, ARK significantly reduced positions in some biopharmaceutical and streaming media stocks:
$Veracyte (VCYT.US)$ became the most heavily 'dumped' target this time, with a staggering 131,900 shares sold.
$Roku Inc (ROKU.US)$ was reduced by 34,800 shares. As one of ARK's former top holdings, the ongoing reduction might indicate that Cathie Wood is shifting funds from mature streaming platforms to more explosive AI-native applications.
$Illumina (ILMN.US)$ also saw a 22,600-share reduction, showing subtle shifts in ARK’s focus within the gene sequencing space.

Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comments (10)
to post a comment
15
28
